Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C4H3ClN2O2 |
| Molecular Weight | 146.532 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=CNC(=O)NC1=O
InChI
InChIKey=ZFTBZKVVGZNMJR-UHFFFAOYSA-N
InChI=1S/C4H3ClN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9)
| Molecular Formula | C4H3ClN2O2 |
| Molecular Weight | 146.532 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| N(1)-C(5')-linked dimer hydrates of 5-substituted uracils produced by anodic oxidation in aqueous solution. | 2001 Apr 6 |
|
| An improved resazurin-based cytotoxicity assay for hepatic cells. | 2002 |
|
| Detection and quantification of 5-chlorocytosine in DNA by stable isotope dilution and gas chromatography/negative ion chemical ionization/mass spectrometry. | 2002 Feb |
|
| 5-Chlorouracil, a marker of DNA damage from hypochlorous acid during inflammation. A gas chromatography-mass spectrometry assay. | 2003 Aug 29 |
|
| Phase I study of irinotecan and S-1 combination therapy in patients with metastatic gastric cancer. | 2003 Dec |
|
| Phagocytes produce 5-chlorouracil and 5-bromouracil, two mutagenic products of myeloperoxidase, in human inflammatory tissue. | 2003 Jun 27 |
|
| Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies. | 2004 Aug 1 |
|
| Influence of halogenation on the properties of uracil and its noncovalent interactions with alkali metal ions. Threshold collision-induced dissociation and theoretical studies. | 2004 Dec 15 |
|
| Electron attachment to chlorouracil: a comparison between 6-ClU and 5-ClU. | 2004 Jan 8 |
|
| Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 1: discovery of novel orally active inhibitors of human thymidine phosphorylase. | 2004 Jul 1 |
|
| Measurement of drug release from microcarriers by microdialysis. | 2005 Jul |
|
| Hydrophilic interaction liquid chromatography-APCI-mass spectrometry determination of 5-fluorouracil in plasma and tissues. | 2005 Jul 15 |
|
| Myeloperoxidase generates 5-chlorouracil in human atherosclerotic tissue: a potential pathway for somatic mutagenesis by macrophages. | 2006 Feb 10 |
|
| Controlled delivery of 5-chlorouracil using poly(ortho esters) in filtering surgery for glaucoma. | 2008 Jul |
|
| Significance of 5-fluorouracil-related enzyme activities in predicting sensitivity to 5-fluorouracil in bladder carcinoma. | 2009 Apr |
|
| Base pairing configuration and stability of an oligonucleotide duplex containing a 5-chlorouracil-adenine base pair. | 2009 Aug 11 |
|
| pH-Dependent configurations of a 5-chlorouracil-guanine base pair. | 2009 Dec 1 |
|
| Polymerase incorporation and miscoding properties of 5-chlorouracil. | 2010 Apr 19 |
|
| Paclitaxel inhibits growth, migration and collagen production of human Tenon's fibroblasts--potential use in drug-eluting glaucoma drainage devices. | 2010 Feb |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 00:42:09 GMT 2023
by
admin
on
Sat Dec 16 00:42:09 GMT 2023
|
| Record UNII |
7LQ4V03RNY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1820-81-1
Created by
admin on Sat Dec 16 00:42:09 GMT 2023 , Edited by admin on Sat Dec 16 00:42:09 GMT 2023
|
PRIMARY | |||
|
15758
Created by
admin on Sat Dec 16 00:42:09 GMT 2023 , Edited by admin on Sat Dec 16 00:42:09 GMT 2023
|
PRIMARY | |||
|
217-339-7
Created by
admin on Sat Dec 16 00:42:09 GMT 2023 , Edited by admin on Sat Dec 16 00:42:09 GMT 2023
|
PRIMARY | |||
|
1279054
Created by
admin on Sat Dec 16 00:42:09 GMT 2023 , Edited by admin on Sat Dec 16 00:42:09 GMT 2023
|
PRIMARY | |||
|
7LQ4V03RNY
Created by
admin on Sat Dec 16 00:42:09 GMT 2023 , Edited by admin on Sat Dec 16 00:42:09 GMT 2023
|
PRIMARY | |||
|
60762
Created by
admin on Sat Dec 16 00:42:09 GMT 2023 , Edited by admin on Sat Dec 16 00:42:09 GMT 2023
|
PRIMARY | |||
|
28172
Created by
admin on Sat Dec 16 00:42:09 GMT 2023 , Edited by admin on Sat Dec 16 00:42:09 GMT 2023
|
PRIMARY | |||
|
DTXSID7075137
Created by
admin on Sat Dec 16 00:42:09 GMT 2023 , Edited by admin on Sat Dec 16 00:42:09 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
USP Peak Value = 0.15%
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
